Wandena S. Siegel-Lakhai

Statistics

Publications

Citations

H-Index

Active since

2005

Affiliations

Utrecht University(Current)

The Netherlands Cancer Institute

Wandena S. Siegel-Lakhai is an author at Utrecht University specializing in oncology, pharmacokinetics of anticancer drugs, and clinical pharmacology.

Publications per year

2005–2008

Publications

Phase I Pharmacokinetic Study of the Safety and Tolerability of Lapatinib (GW572016) in Combination with Oxaliplatin/Fluorouracil/Leucovorin (FOLFOX4) in Patients with Solid Tumors

Wandena S. Siegel-Lakhai, Jos H. Beijnen, Walter L. Vervenne et al. · Clinical Cancer Research · 2007 · 47 citations

Medicine, Oncology, Pharmacology +10

Phase I and pharmacological study of the farnesyltransferase inhibitor tipifarnib (Zarnestra®, R115777) in combination with gemcitabine and cisplatin in patients with advanced solid tumours

Wandena S. Siegel-Lakhai, Mirjam Crul, S. Zhang et al. · British Journal of Cancer · 2005 · 25 citations · Full text

Pharmacy, Oncology, Pharmacology +17

A dose-escalation study of indisulam in combination with capecitabine (Xeloda) in patients with solid tumours

Wandena S. Siegel-Lakhai, Anthe S. Zandvliet, Alwin D. R. Huitema et al. · British Journal of Cancer · 2008 · 17 citations · Full text

Medicine, Oncology, Pharmacology +14

1–3 of 3